These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4448539)

  • 41. Management of the nephrotic syndrome in children.
    McDonald R
    S Afr Med J; 1970 Nov; 44(46):1315-7. PubMed ID: 5485560
    [No Abstract]   [Full Text] [Related]  

  • 42. A clinicopathological study of nephrotic syndrome and role of immunosuppressive therapy.
    Prasad R; Dayal RS; Srivastava VK; Bhatnagar AK; Jain S; Kapur S
    Indian Pediatr; 1980 Dec; 17(12):923-9. PubMed ID: 7251119
    [No Abstract]   [Full Text] [Related]  

  • 43. A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis.
    Futrakul P
    Int J Pediatr Nephrol; 1980 Mar; 1(1):18-21. PubMed ID: 7343523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prednisone and immunosuppressive agents in the therapy of nephrotic syndrome in infancy].
    Gabriele C; Gabriele S; Bandiermonte Z
    Minerva Pediatr; 1971 Apr; 23(16):725-32. PubMed ID: 5555704
    [No Abstract]   [Full Text] [Related]  

  • 45. Minimal-lesion nephrotic syndrome with early resistance to steroid therapy.
    Siegel NJ; Gur A; Krassner LS; Kashgarian M
    J Pediatr; 1975 Sep; 87(3):377-80. PubMed ID: 1165516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF; Brodeh J
    J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Primary nephrotic syndromes in children in Iran].
    Bodaghi E; Chamsa AM
    Ann Pediatr (Paris); 1978 Jan; 25(1):61-70. PubMed ID: 16114307
    [No Abstract]   [Full Text] [Related]  

  • 48. Late nonresponsiveness to steroids in children with the nephrotic syndrome.
    Trainin EB; Boichis H; Spitzer A; Edelmann CM; Greifer I
    J Pediatr; 1975 Oct; 87(4):519-23. PubMed ID: 1159578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nephrotic syndrome.
    Rahman M; Nazrul Islam KM; Hassan S
    Bangladesh Med Res Counc Bull; 1977 Dec; 3(2):77-86. PubMed ID: 615592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nephrotic syndrome and diffuse mesangial proliferative glomerulonephritis in children.
    Garin EH; Donnelly WH; Geary D; Richard GA
    Am J Dis Child; 1983 Feb; 137(2):109-13. PubMed ID: 6849298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclophosphamide therapy in idiopathic nephrotic syndrome--a new treatment.
    Dundon S; Carroll R; Dunleavy M; Raftery J
    J Ir Med Assoc; 1971 May; 64(411):243-6. PubMed ID: 5578246
    [No Abstract]   [Full Text] [Related]  

  • 52. [Idiopathic nephrotic syndrome with minimal glomerular lesions or with diffuse mesangial proliferation. Comparison of 2 groups of children].
    Giani M; Ripanti G; Stucchi C; Bettinelli A; Bertoletti A; Claris Appiani A; Ghio L; Gaboardi F; Edefonti A
    Minerva Nefrol; 1980; 27(4):539-42. PubMed ID: 7254677
    [No Abstract]   [Full Text] [Related]  

  • 53. Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.
    Garin EH; Pryor ND; Fennell RS; Richard GA
    J Pediatr; 1978 Feb; 92(2):304-8. PubMed ID: 621614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hereditary nephritis associated with nephrotic syndrome.
    Karpouzas J; Psimenos G; Frimas C
    Helv Paediatr Acta; 1974 Dec; 29(6):589-94. PubMed ID: 4457517
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cyclophosphamide therapy of nephrotic syndrome in childhood].
    Krepler P; Rosenkranz A; Obiditsch-Mayer I; Stockinger L; Schatz H; Fritzsche H
    Arch Kinderheilkd; 1970; 181(3):268-82. PubMed ID: 4922851
    [No Abstract]   [Full Text] [Related]  

  • 57. [Use of leukeran in the treatment of nephrotic syndrome in children].
    Kucharska K; Sancewicz-Pach K
    Pediatr Pol; 1978 Aug; 53(8):973-8. PubMed ID: 693147
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical analysis of 10 refractory cases of idiopathic nephrotic syndrome in children treated with combined traditional Chinese medicine and western medicine].
    Zhao Z
    Zhong Xi Yi Jie He Za Zhi; 1984 Oct; 4(10):607-9, 580. PubMed ID: 6240329
    [No Abstract]   [Full Text] [Related]  

  • 59. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM; Bercowsky A; Osofsky SG; Soothill JF
    Lancet; 1975 Jan; 1(7898):55-8. PubMed ID: 46019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children].
    Norero C; Delucchi A; Lagos E; Rosati P
    Rev Med Chil; 1996 May; 124(5):567-72. PubMed ID: 9035508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.